Our results were verified by qPCR for the selected cytokines involved in immune cell activation and migration (CCL2, CCL3, CCL4, CCL5, CX3CL1), representing potential therapeutic targets in atherosclerosis. This evidence concerns the gene CCL5 and atherosclerosis.